-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIDGEBIO ONCOLOGY THERAPEUTICS INC : LEERINK PARTNERS RAISES TARGET PRICE TO $32 FROM $25

Reuters·01/08/2026 14:26:58

Please log in to view news